[1]
K. B. Shaha, A. Adhikari, J. R. Cho, B. Pandey, Y. Sharma, and S. Safi, “Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth”, Nep. Med. J., vol. 3, no. 1, pp. 309–312, May 2020.